Special Issue "Applications of Additive Manufacturing in Pharmaceutics"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: closed (31 March 2021).
We would like to invite you to contribute to this Special Issue, entitled “Applications of Additive Manufacturing in Pharmaceutics”.
Additive manufacturing technologies, namely 2D and 3D printing, have headily entered the pharmaceutical world, because the conventional manufacturing methods for drug products have some evident limitations. Traditional manufacturing solutions are limited in the provision of patient-tailored easily recognizable medicine. Furthermore, a simple design of the conventional dosage forms makes them easier to counterfeit. Finally, flexible on-demand production of dosage forms near end-users is scanty with the conventional operation procedures and regulations.
In this regard, the nature and operating principles of additive manufacturing technologies, open up new possibilities for development of innovative dosage forms with unique design and enhanced functionality that would overcome the physiological limitations of the gastrointestinal tract. However, these technologies if used alone have their own limitations. Therefore, combining e.g., 3D printing with another manufacturing solution(s) can minimize the drawbacks and couple the advantages of both technologies. Furthermore, a small footprint of 3D printers enables their incorporation in the settings near end-users, e.g., hospital pharmacies, for on-demand production of pharmaceuticals. This would require miniaturized, rapid and non-destructive quality control methods. In addition, such potential on-demand drug manufacturing would need to meet the requirements of the current regulations and/or lead to proposal and approval of new ones.
This Special Issue invites the submission of articles dealing with the following topics:
- Innovative dosage forms with improved functionality
- Pharmaceutical dosage forms manufactured by combination of two or more techniques, where one is 3D printing
- Non-destructive and preferably portable quality control systems for printable pharmaceuticals
- Regulatory challenges and possible scenarios to make flexible production of printable pharmaceuticals a reality
I am looking forward to receiving your contributions!
Assoc. Prof. Natalja Genina
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- 2D printing
- 3D printing
- dosage forms
- quality control systems
- regulatory challenges